We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DMP:ASXDomino's Pizza Enterprises Limited Analysis

Data as of 2026-03-16 - not real-time

A$18.66

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Domino's Pizza Enterprises (DMP) is trading at AUD 18.66, which sits below its 20‑day (19.75) and 50‑day (21.64) simple moving averages, indicating short‑term weakness. The RSI of 39.6 suggests the stock is edging toward oversold territory, while the MACD remains marginally bearish, reinforcing a cautious technical outlook. Price action is hugging the calculated support level of AUD 17.27 and faces resistance near AUD 22.50, with volume trending lower and 30‑day volatility elevated at roughly 60%, highlighting a potentially choppy trading environment. Fundamentally, the company posted a 5.5% revenue contraction, carries a heavy debt load (debt‑to‑equity ≈ 181%) and a payout ratio exceeding 120%, casting doubt on dividend sustainability. The DCF‑derived fair value of about AUD 5.25 starkly contrasts with the current price, flagging the stock as materially overvalued. Recent management commentary emphasizes a strategic “reset” toward franchise health and cost discipline, but the transition will require time to translate into earnings growth.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Price near technical support (AUD 17.27)
  • RSI indicating oversold conditions
  • Extreme‑greed market sentiment may spur a short‑term bounce

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Strategic shift toward a value‑driven franchise model
  • High leverage and unsustainable dividend payout
  • Forward PE of ~13 suggests modest upside if earnings improve

Long Term

> 3 years
Cautious
Model confidence: 5/10

Key Factors

  • DCF fair value far below current price
  • Persistent debt burden and weak profit margins
  • Dividend yield not supported by cash flow

Key Metrics & Analysis

Financial Health

Revenue Growth-5.50%
Profit Margin2.65%
P/E Ratio29.6
ROE9.07%
ROA3.92%
Debt/Equity180.99
P/B Ratio2.6
Op. Cash FlowA$173.0M
Free Cash FlowA$122.2M

Technical Analysis

TrendNeutral
RSI39.6
SupportA$17.27
ResistanceA$22.50
MA 20A$19.75
MA 50A$21.64
MA 200A$19.10
MACDBearish
VolumeDecreasing
Fear & Greed Index75.11

Valuation

Fair ValueA$5.25
Target PriceA$21.75
Upside/Downside16.58%
GradeOvervalued
TypeValue
Dividend Yield2.49%

Risk Assessment

Beta0.47
Volatility59.57%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.